Home/Filings/4/0001415889-24-014573
4//SEC Filing

Panzara Michael A. 4

Accession 0001415889-24-014573

CIK 0001620463other

Filed

May 23, 8:00 PM ET

Accepted

May 24, 6:56 PM ET

Size

5.7 KB

Accession

0001415889-24-014573

Insider Transaction Report

Form 4
Period: 2024-05-24
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-05-24+20,90020,900 total
    Exercise: $2.64Exp: 2034-05-23Common Stock (20,900 underlying)
Footnotes (1)
  • [F1]The shares subject to the option will vest on the earlier of (i) May 24, 2025, or (ii) the day immediately before the date of the next annual meeting of the Issuer's stockholders that occurs after May 24, 2024. The option reported was granted pursuant to the terms of the Issuer's Outside Director Compensation Policy.

Issuer

Athira Pharma, Inc.

CIK 0001620463

Entity typeother

Related Parties

1
  • filerCIK 0001679039

Filing Metadata

Form type
4
Filed
May 23, 8:00 PM ET
Accepted
May 24, 6:56 PM ET
Size
5.7 KB